Sarepta Therapeutics, Inc.·4

Sep 5, 9:30 PM ET

Estepan Ian Michael 4

4 · Sarepta Therapeutics, Inc. · Filed Sep 5, 2025

Insider Transaction Report

Form 4
Period: 2025-09-03
Estepan Ian Michael
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-09-03+93,875156,487 total
  • Award

    Common Stock

    2025-09-03+50,000206,487 total
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company.
  • [F2]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4